Dermatology
Hyperpigmentation
0
Pipeline Programs↗
1
Active Trials↗
1
Companies Involved↗
Hyperpigmentation is an early-stage landscape with 0 programs across 1 company. The most active players are Kenvue Brands.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
13
clinical trials
Completed9 · 69%
Withdrawn2 · 15%
Unknown status1 · 8%
Recruiting1 · 8%
Clinical Trials
Trial Activity
13 trials
Ascorbic Acid Versus Diode Laser in the Treatment of Gingival Hyperpigmentation
Completed·—·Phase 4·NCT03252418·10 enrolled
Tranexamic Acid vs Fractional CO2 Laser in Post-acne Hyperpigmentation
Unknown status·—·N/A·NCT03765021·25 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)